MedTrace Logo

Physicians' Health Study

NCT00000500 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2021-01-28

No results posted yet for this study

Summary

To assess the effect on cardiovascular mortality of alternate-day consumption of 325 milligrams of aspirin and, secondarily, the effect on cancer incidence of alternate-day consumption of 50 milligrams of beta-carotene.

Conditions

Interventions

DRUG

aspirin

DRUG

carotene

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Brigham and Women's Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE

Eligibility

Min Age
40 Years
Max Age
84 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1981-09-30
Primary Completion
1995-12-31
Completion
1996-12-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000500 on ClinicalTrials.gov